Additionally, in our study, ACE2 inhibited the phosphorylation of ERK1/2 in breast cancer cells, which revealed that ERK signalling participated in the ACE2-mediated regulation of the expression of VEGFa. This evidence concerns the gene MAPK3 and breast carcinoma.